Mohammad Yaser Kiarudi, Seyed Hossein Ghavami Shahri, Acieh Es'haghi, Bahare Gharib, Mohammad-Reza Ansari-Astaneh
{"title":"布比卡因在斜视非手术治疗中的应用综述。","authors":"Mohammad Yaser Kiarudi, Seyed Hossein Ghavami Shahri, Acieh Es'haghi, Bahare Gharib, Mohammad-Reza Ansari-Astaneh","doi":"10.1080/09273972.2022.2135743","DOIUrl":null,"url":null,"abstract":"<p><p>Bupivacaine (BUP) is an anesthetic from the family of aminoacyl anesthetics and has the highest myotoxicity among other groups of anesthetics. Intramuscular injection of BUP first causes acute libriform lysis and subsequently with the regeneration process, stronger myofibrils are formed within 3-4 weeks. Satellite cells, which are actually myogenic stem cells, are preserved in the early stage and during the destruction of muscle fibers. In fact, these cells are responsible for the subsequent regeneration of fibers. BUP is one of the few medicines that is able to increase muscle strength. In animal studies on rabbits, a decrease has been observed in the diameter of the global layer in the first week and an increase in type-I myosin occurs after 60 days, especially in the global muscle layer. There are numerous studies according to BUP injection for the non-surgical management of horizontal strabismus. To intensify the effects of the injection, botulinum toxin injection can also be used simultaneously in the antagonist muscles. In general, although the rate of improvement in strabismus varied among different studies, BUP injection alone corrects about 5-8 prism diopters. Together with botulinum toxin, BUP corrects about 15 prism diopters. The stability of this improvement is up to 10 years after injection. No significant difference has been observed in response rate between patients with esotropia and exotropia. Unlike the large molecule of botulinum toxin, which spreads slowly to its site of action, the BUP molecule is small and must be in direct contact with myofibrils before absorption into the bloodstream to exert its effect. Therefore, the injection volume should be about 3 cc with a concentration of 0.75 g per deciliter. Although BUP is promising non-surgical strabismus management, especially in small angle and residual horizontal strabismus, however, it has its own limitations. The need for direct infusion of a relatively large volume of BUP may be one of its major drawbacks that limits its usage in an office method.</p>","PeriodicalId":51700,"journal":{"name":"Strabismus","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Applications of bupivacaine in the non-surgical treatments of strabismus: a review.\",\"authors\":\"Mohammad Yaser Kiarudi, Seyed Hossein Ghavami Shahri, Acieh Es'haghi, Bahare Gharib, Mohammad-Reza Ansari-Astaneh\",\"doi\":\"10.1080/09273972.2022.2135743\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Bupivacaine (BUP) is an anesthetic from the family of aminoacyl anesthetics and has the highest myotoxicity among other groups of anesthetics. Intramuscular injection of BUP first causes acute libriform lysis and subsequently with the regeneration process, stronger myofibrils are formed within 3-4 weeks. Satellite cells, which are actually myogenic stem cells, are preserved in the early stage and during the destruction of muscle fibers. In fact, these cells are responsible for the subsequent regeneration of fibers. BUP is one of the few medicines that is able to increase muscle strength. In animal studies on rabbits, a decrease has been observed in the diameter of the global layer in the first week and an increase in type-I myosin occurs after 60 days, especially in the global muscle layer. There are numerous studies according to BUP injection for the non-surgical management of horizontal strabismus. To intensify the effects of the injection, botulinum toxin injection can also be used simultaneously in the antagonist muscles. In general, although the rate of improvement in strabismus varied among different studies, BUP injection alone corrects about 5-8 prism diopters. Together with botulinum toxin, BUP corrects about 15 prism diopters. The stability of this improvement is up to 10 years after injection. No significant difference has been observed in response rate between patients with esotropia and exotropia. Unlike the large molecule of botulinum toxin, which spreads slowly to its site of action, the BUP molecule is small and must be in direct contact with myofibrils before absorption into the bloodstream to exert its effect. Therefore, the injection volume should be about 3 cc with a concentration of 0.75 g per deciliter. Although BUP is promising non-surgical strabismus management, especially in small angle and residual horizontal strabismus, however, it has its own limitations. The need for direct infusion of a relatively large volume of BUP may be one of its major drawbacks that limits its usage in an office method.</p>\",\"PeriodicalId\":51700,\"journal\":{\"name\":\"Strabismus\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Strabismus\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/09273972.2022.2135743\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strabismus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/09273972.2022.2135743","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
布比卡因(Bupivacaine, BUP)是氨基酰基麻醉药家族的一种麻醉剂,在其他麻醉药组中具有最高的肌毒性。肌内注射BUP首先引起急性纤原溶解,随后随着再生过程,在3-4周内形成较强的肌原纤维。卫星细胞,实际上是肌源性干细胞,在肌纤维破坏的早期阶段被保存下来。事实上,这些细胞负责随后的纤维再生。BUP是少数几种能够增加肌肉力量的药物之一。在对家兔进行的动物研究中,第一周观察到全肌层直径减小,60天后出现i型肌球蛋白增加,特别是在全肌层。目前有大量研究表明BUP注射用于非手术治疗水平斜视。为了加强注射的效果,肉毒杆菌毒素注射也可以同时用于拮抗剂肌肉。一般来说,虽然斜视的改善率在不同的研究中有所不同,但单独注射BUP可矫正约5-8棱镜屈光度。与肉毒杆菌毒素一起,BUP矫正了大约15个棱镜屈光度。这种改善的稳定性在注射后长达10年。内斜视和外斜视患者的反应率无显著差异。与大分子肉毒杆菌毒素不同,肉毒杆菌毒素会缓慢地扩散到作用部位,BUP分子很小,在被血液吸收之前必须与肌原纤维直接接触才能发挥作用。因此,注射量应为3cc左右,浓度为0.75 g /分升。虽然BUP是一种很有前途的非手术斜视治疗方法,特别是在小角度斜视和残余水平斜视中,但它也有其局限性。需要直接注入相对大量的BUP可能是其主要缺点之一,限制了其在办公室方法中的使用。
Applications of bupivacaine in the non-surgical treatments of strabismus: a review.
Bupivacaine (BUP) is an anesthetic from the family of aminoacyl anesthetics and has the highest myotoxicity among other groups of anesthetics. Intramuscular injection of BUP first causes acute libriform lysis and subsequently with the regeneration process, stronger myofibrils are formed within 3-4 weeks. Satellite cells, which are actually myogenic stem cells, are preserved in the early stage and during the destruction of muscle fibers. In fact, these cells are responsible for the subsequent regeneration of fibers. BUP is one of the few medicines that is able to increase muscle strength. In animal studies on rabbits, a decrease has been observed in the diameter of the global layer in the first week and an increase in type-I myosin occurs after 60 days, especially in the global muscle layer. There are numerous studies according to BUP injection for the non-surgical management of horizontal strabismus. To intensify the effects of the injection, botulinum toxin injection can also be used simultaneously in the antagonist muscles. In general, although the rate of improvement in strabismus varied among different studies, BUP injection alone corrects about 5-8 prism diopters. Together with botulinum toxin, BUP corrects about 15 prism diopters. The stability of this improvement is up to 10 years after injection. No significant difference has been observed in response rate between patients with esotropia and exotropia. Unlike the large molecule of botulinum toxin, which spreads slowly to its site of action, the BUP molecule is small and must be in direct contact with myofibrils before absorption into the bloodstream to exert its effect. Therefore, the injection volume should be about 3 cc with a concentration of 0.75 g per deciliter. Although BUP is promising non-surgical strabismus management, especially in small angle and residual horizontal strabismus, however, it has its own limitations. The need for direct infusion of a relatively large volume of BUP may be one of its major drawbacks that limits its usage in an office method.